Sumitomo Mitsui Trust Group
MIRM icon

Sumitomo Mitsui Trust Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$251K Sell
2,148
-772
-26% -$77.5K ﹤0.01% 1046
2026
Q1 		$270K Sell
2,920
-118
-4% -$11.1K ﹤0.01% 1008
2025
Q4 		$240K Buy
+3,038
New +$218K ﹤0.01% 1026

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group's MIRM Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group reduced its Mirum Pharmaceuticals (MIRM) stake by 26% in Q2 2026, selling an estimated $77.5K and leaving 2,148 shares worth $251K. The position accounts for ﹤0.01% of the portfolio, ranked #1046.

Sumitomo Mitsui Trust Group first reported a position in MIRM in Q4 2025 and has held it in 3 quarters since. The position peaked at $270K in Q1 2026. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 2,148 shares of Mirum Pharmaceuticals worth $251K as of Q2 2026.
  • Sumitomo Mitsui Trust Group sold 772 Mirum Pharmaceuticals shares in Q2 2026, an estimated $77.5K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #1046 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Mirum Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Sumitomo Mitsui Trust Group's Mirum Pharmaceuticals position peaked at $270K in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.